دورية أكاديمية

Methacrylate Cationic Nanoparticles Activity against Different Gram-Positive Bacteria.

التفاصيل البيبلوغرافية
العنوان: Methacrylate Cationic Nanoparticles Activity against Different Gram-Positive Bacteria.
المؤلفون: Nam-Cha SH; Department of Pathology, Complejo Hospitalario Universitario, 02006 Albacete, Spain., Ocaña AV; Instituto de Investigación en Discapacidades Neurológicas (IDINE), University of Castilla-La Mancha, 02001 Albacete, Spain., Pérez-Tanoira R; Clinical Microbiology Department, Hospital Universitario Príncipe de Asturias, 28805 Madrid, Spain.; Biomedicine y Biotechnology Department, School of Medicine, University of Alcalá de Henares, 28054 Madrid, Spain., Aguilera-Correa JJ; Clinical Microbiology Department, IIS-Fundacion Jimenez Diaz-UAM, 28040 Madrid, Spain., Domb AJ; Institute of Drug Research, School of Pharmacy-Faculty of Medicine, Center for Nanoscience and Nanotechnology and The Alex Grass Center for Drug Design and Synthesis, The Hebrew University of Jerusalem, Jerusalem 91120, Israel., Ruiz-Grao MC; Department of Nursing, University of Castilla-La Mancha, 02071 Albacete, Spain.; Health and Social Research Center, University of Castilla-La Mancha, 16071 Cuenca, Spain., Cebada-Sánchez S; Department of Nursing, University of Castilla-La Mancha, 02071 Albacete, Spain., López-Gónzalez Á; Department of Nursing, University of Castilla-La Mancha, 02071 Albacete, Spain., Molina-Alarcón M; Instituto de Investigación en Discapacidades Neurológicas (IDINE), University of Castilla-La Mancha, 02001 Albacete, Spain.; Department of Nursing, University of Castilla-La Mancha, 02071 Albacete, Spain., Pérez-Martínez J; BIOTYC Foundation, C/Blasco de Garay 27, 02003 Albacete, Spain.; Department of Nephrology, Complejo Hospitalario Universitario, 02006 Albacete, Spain., Pérez-Martínez FC; Instituto de Investigación en Discapacidades Neurológicas (IDINE), University of Castilla-La Mancha, 02001 Albacete, Spain.; Department of Nursing, University of Castilla-La Mancha, 02071 Albacete, Spain.; BIOTYC Foundation, C/Blasco de Garay 27, 02003 Albacete, Spain.
المصدر: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2023 Mar 07; Vol. 12 (3). Date of Electronic Publication: 2023 Mar 07.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101637404 Publication Model: Electronic Cited Medium: Print ISSN: 2079-6382 (Print) Linking ISSN: 20796382 NLM ISO Abbreviation: Antibiotics (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, 2012-
مستخلص: Nanotechnology is a developing field that has boomed in recent years due to the multiple qualities of nanoparticles (NPs), one of which is their antimicrobial capacity. We propose that NPs anchored with 2-(dimethylamino)ethyl methacrylate (DMAEMA) have antibacterial properties and could constitute an alternative tool in this field. To this end, the antimicrobial effects of three quaternised NPs anchored with DMAEMA were studied. These NPs were later copolymerized using different methylmethacrylate (MMA) concentrations to evaluate their role in the antibacterial activity shown by NPs. Clinical strains of Staphylococcus aureus , S. epidermidis , S. lugdunensis and Enterococcus faecalis were used to assess antibacterial activity. The minimal inhibitory concentration (MIC) was determined at the different concentrations of NPs to appraise antibacterial activity. The cytotoxic effects of the NPs anchored with DMAEMA were determined in NIH 3 T 3 mouse fibroblast cultures by MTT assays. All the employed NPs were effective against the studied bacterial strains, although increasing concentrations of the MMA added during the synthesis process diminished these effects without altering toxicity in cell cultures. To conclude, more studies with other copolymers are necessary to improve the antibacterial effects of NPs anchored with DMAEMA.
References: Nature. 2006 Nov 16;444(7117):267-9. (PMID: 17108940)
Adv Exp Med Biol. 2014;811:73-91. (PMID: 24683028)
Trends Biotechnol. 2012 Oct;30(10):499-511. (PMID: 22884769)
Chem Cent J. 2013 Jan 19;7(1):11. (PMID: 23331621)
Int J Syst Bacteriol. 1999 Jul;49 Pt 3:1181-92. (PMID: 10425778)
Int J Nanomedicine. 2010 Apr 15;5:277-83. (PMID: 20463943)
IET Nanobiotechnol. 2015 Dec;9(6):342-8. (PMID: 26647809)
J Alzheimers Dis. 2012;31(4):697-710. (PMID: 22695620)
Part Fibre Toxicol. 2005 Oct 06;2:8. (PMID: 16209704)
Materials (Basel). 2020 Dec 31;14(1):. (PMID: 33396469)
Environ Pollut. 2007 Nov;150(1):5-22. (PMID: 17658673)
Small. 2010 Jan;6(1):12-21. (PMID: 19844908)
Toxicol In Vitro. 2019 Dec;61:104610. (PMID: 31362040)
Part Fibre Toxicol. 2009 Apr 30;6:14. (PMID: 19405955)
Int J Nanomedicine. 2012;7:6003-9. (PMID: 23233805)
Nano Lett. 2012 Jul 11;12(7):3587-91. (PMID: 22716029)
Arch Toxicol. 2011 Jul;85(7):723-31. (PMID: 20499226)
Biomacromolecules. 2006 Aug;7(8):2291-6. (PMID: 16903673)
Int J Syst Bacteriol. 1999 Apr;49 Pt 2:725-8. (PMID: 10319495)
Sci Rep. 2014 Apr 11;4:4551. (PMID: 24722502)
IET Nanobiotechnol. 2017 Dec;11(8):965-972. (PMID: 29155396)
Mol Microbiol. 2013 May;88(4):664-72. (PMID: 23600697)
J Clin Microbiol. 2008 Mar;46(3):1019-25. (PMID: 18174295)
J Immunol Methods. 1983 Dec 16;65(1-2):55-63. (PMID: 6606682)
J Control Release. 2009 Apr 2;135(1):35-43. (PMID: 19110018)
Clin Microbiol Infect. 2012 Mar;18(3):268-81. (PMID: 21793988)
Curr Med Chem. 2010;17(6):585-94. (PMID: 20015030)
Langmuir. 2007 Apr 10;23(8):4448-54. (PMID: 17358090)
Asian Pac J Cancer Prev. 2014;15(16):6773-9. (PMID: 25169524)
Infect Immun. 2001 May;69(5):3423-6. (PMID: 11292767)
Methods Mol Biol. 2012;926:1-12. (PMID: 22975953)
Enferm Infecc Microbiol Clin. 2010 Nov;28 Suppl 4:4-9. (PMID: 21458693)
Emerg Top Life Sci. 2020 Dec 17;4(6):551-554. (PMID: 33295610)
Clin Infect Dis. 2021 Jan 29;72(Suppl 1):S17-S26. (PMID: 33512523)
Biomacromolecules. 2007 Apr;8(4):1171-7. (PMID: 17348705)
Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33. (PMID: 20805405)
Colloids Surf B Biointerfaces. 2015 Apr 1;128:608-613. (PMID: 25686793)
Environ Sci Pollut Res Int. 2018 Jun;25(16):15765-15773. (PMID: 29582323)
Biomacromolecules. 2010 Feb 8;11(2):443-53. (PMID: 20025269)
Nat Mater. 2006 Sep;5(9):683-96. (PMID: 16946728)
J Travel Med. 2019 Dec 23;26(8):. (PMID: 31115466)
Evid Based Complement Alternat Med. 2015;2015:246012. (PMID: 25861355)
Am J Physiol Renal Physiol. 2014 Oct 1;307(7):F777-82. (PMID: 25056353)
J Clin Microbiol. 2001 Dec;39(12):4296-301. (PMID: 11724835)
Langmuir. 2009 May 5;25(9):5199-208. (PMID: 19317421)
Polymers (Basel). 2020 Jun 28;12(7):. (PMID: 32605222)
JAMA. 1999 Jan 6;281(1):61-6. (PMID: 9892452)
Environ Sci Eur. 2018;30(1):6. (PMID: 29456907)
Environ Health Perspect. 2005 Jul;113(7):823-39. (PMID: 16002369)
Genome Biol Evol. 2017 May 1;9(5):. (PMID: 28444231)
Int J Mol Sci. 2013 May 10;14(5):9906-46. (PMID: 23665898)
Antibiotics (Basel). 2021 Sep 06;10(9):. (PMID: 34572658)
Int J Mol Sci. 2019 Jun 08;20(11):. (PMID: 31181755)
Sci Total Environ. 2011 Mar 15;409(8):1603-8. (PMID: 21310463)
BMC Evol Biol. 2012 Sep 06;12:171. (PMID: 22950675)
J Biomater Sci Polym Ed. 2007;18(3):241-68. (PMID: 17471764)
J Phys Chem B. 2006 Aug 24;110(33):16248-53. (PMID: 16913750)
Curr Pharm Des. 2008;14(22):2184-200. (PMID: 18781971)
Sci Total Environ. 2007 Feb 15;373(2-3):572-5. (PMID: 17173953)
Soft Matter. 2017 May 24;13(20):3777-3782. (PMID: 28480930)
Environ Pollut. 2009 May;157(5):1619-25. (PMID: 19185963)
Clin Microbiol Infect. 2020 May;26(5):596-603. (PMID: 31574341)
Sci Rep. 2021 Aug 11;11(1):16306. (PMID: 34381091)
Langmuir. 2020 Apr 7;36(13):3482-3493. (PMID: 32168453)
Mol Pharm. 2019 Feb 4;16(2):709-723. (PMID: 30589552)
Curr Drug Targets. 2015;16(14):1671-81. (PMID: 26601723)
J Clin Microbiol. 1991 Apr;29(4):738-44. (PMID: 1890175)
فهرسة مساهمة: Keywords: DMAEMA; MMA; antibacterial activity; nanoparticles
تواريخ الأحداث: Date Created: 20230329 Latest Revision: 20230331
رمز التحديث: 20230331
مُعرف محوري في PubMed: PMC10044577
DOI: 10.3390/antibiotics12030533
PMID: 36978400
قاعدة البيانات: MEDLINE
الوصف
تدمد:2079-6382
DOI:10.3390/antibiotics12030533